ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
ANI Pharma (ANIP) Tops Q1 EPS by 4c
May 8, 2018 8:32 AM EDTANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.32, $0.04 better than the analyst estimate of $1.28. Revenue for the quarter came in at $46.5 million versus the consensus estimate of $49.93 million.
ANI Reaffirms Guidance for the Full Year 2018For earnings history and earnings-related data on ANI Pharma (ANIP) click here.
... More